: BIONTECH SAYS DATA INDICATE THAT THE VACCINE IS STILL EFFECTIVE IN PREVENTING COVID-19, ALSO AGAINST OMICRON, IF IT HAS BEEN ADMINISTERED THREE TIMES
: PFIZER INC - DATA INDICATE THAT THIRD DOSE OF BNT162B2 INCREASES NEUTRALIZING ANTIBODY TITERS BY 25-FOLD COMPARED TO TWO DOSES AGAINST OMICRON VARIANT
: PFIZER INC - HAVE HIGH CONFIDENCE THAT IF NEEDED THEY CAN DELIVER AN OMICRON-BASED VACCINE IN MARCH 2022
Comment:
OPTIMISM
Weakness JPY, weakness gold, strength equities
Comment:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
: PFIZER INC - DATA INDICATE THAT THIRD DOSE OF BNT162B2 INCREASES NEUTRALIZING ANTIBODY TITERS BY 25-FOLD COMPARED TO TWO DOSES AGAINST OMICRON VARIANT
: PFIZER INC - HAVE HIGH CONFIDENCE THAT IF NEEDED THEY CAN DELIVER AN OMICRON-BASED VACCINE IN MARCH 2022